Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19465208 | 0.93 | DAO (0.35) | DAOESR1ESR2RXRARXRB | |
| SCHEMBL15747030 | 0.83 | DAO (0.36) | DAOESR1ESR2RXRARXRB | |
| SCHEMBL27437849 | 0.82 | SMN1; SMN2 (0.46) | DAORXRARXRBRXRGNPSR1 | |
| SCHEMBL21712680 | 0.82 | LMNA (0.39) | DAO | |
| SCHEMBL47866 | 0.82 | ESR1 (0.46) | ESR1ESR2 | |
| SCHEMBL29728144 | 0.82 | ESR1 (0.46) | ESR1ESR2 | |
| SCHEMBL21514087 | 0.80 | PPARG (0.37) | DAOESR1 | |
| SCHEMBL13538944 | 0.80 | ESR1 (0.50) | ESR1ESR2 | |
| SCHEMBL22000812 | 0.80 | TAAR1 (0.31) | DAOESR1ESR2TAAR1 | |
| SCHEMBL15746150 | 0.76 | KIF11 (0.42) | DAOESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10471397-B2 | High performance facilitated transport membranes for olefin/paraffin separations | UOP LLC (US) | 2019-11-12 | — | — | US | disclosed |
| US-20190255490-A1 | HIGH PERFORMANCE FACILITATED TRANSPORT MEMBRANES FOR OLEFIN/PARAFFIN SEPARATIONS | UOP LLC (US) | 2019-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190255490-A1 | HIGH PERFORMANCE FACILITATED TRANSPORT MEMBRANES FOR OLEFIN/PARAFFIN SEPARATIONS | SLC43A1, SLC7A1, SLCO4C1 | DAO 3249/4885ESR1 815/4885ESR2 1561/4885 |
| US-10471397-B2 | High performance facilitated transport membranes for olefin/paraffin separations | SLC43A1, SLC7A1, SLCO4C1 | DAO 3249/4885ESR1 815/4885ESR2 1561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.